MedQuist Evaluating Whether a Sale of the Company is in the Best Interests of the Company and its Sh...( MT. LAUREL N.J. Nov. 2 /- MedQuis...),Health
MT. LAUREL, N.J., Nov. 2 /PRNewswire-FirstCall/ -- MedQuist Inc. (Pink Sheets: MEDQ) announces that its Board of Directors, in connection with its previously-disclosed review of strategic alternatives for the Company, is evaluating whether a sale of the Company is in the best interests of the Company and its shareholders, in light of the announcement earlier today by Koninklijke Philips Electronics N.V. ("Philips") of its decision to proceed with the sale of its 70% ownership interest in the Company if a satisfactory price and other acceptable terms can be realized. There is no assurance that any sale transaction will occur as a result of the evaluation.
About MedQuist:
MedQuist is a leading provider of clinical documentation workflow solutions in support of the electronic health record. MedQuist provides electronic medical transcription, health information and document management products and services, including digital dictation, speech recognition, Web- based transcription, electronic signature, medical coding, mobile dictation devices, and outsourcing services.
"Safe Harbor" Statement under the U.S. Private Securities Litigation
Reform Act of 1995: Statements in this press release regarding MedQuist's
business which are not historical facts are "forward-looking statements"
that involve risks and uncertainties, including without limitation that the
Company's evaluation of whether a sale of the Company is in the best
interest of the Company and its shareholders may not result in a sale of
the Company, and that any potential sale transaction reviewed by the
Company may not be attractive to shareholders and may not result in
enhanced shareholder value. Actual outcomes and results may differ
materially from what is expressed or forecasted in forward- looking
statements. As a result, forward-looking statements speak only as of the
date they were made, and the Company undertakes no obligation to publicly
update or revise any forward-looking sta
'/>"/>
| SOURCE MedQuist Inc. Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. Evaluating The Risks and Benefits of Hormone Therapy
2. Evaluating The Risk Factors Of Osteoporosis
3. Evaluating The Benefits Of A Low – carb Diet
4. US Doctors re-evaluating Conjoined Twin Surgery
5. VA Should Revise Its Methods for Evaluating PTSD in Ex-military Personnel
6. Experts Question Whether Expert Patient Programmes Cut Healthcare Use
7. US Court Asked to Decide Whether Childhood Vaccines can Cause Autism
8. Researchers To Test Whether ADHD Medication Helps Young Adults While Driving
9. Medicis Pharmaceutical company enters pediatric market
10. Problems Of a Growing Company
11. Teenagers Take More Risk-Taking Behaviors In The Company Of Same Sex Friends
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |